LLY : Summary for Eli Lilly and Company - Yahoo Finance

U.S. Markets close in 5 hrs 34 mins

Eli Lilly and Company (LLY)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
81.57+0.50 (+0.62%)
As of 10:26AM EST. Market open.
People also watch
BMYMRKABTGSKJNJ
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close81.07
Open81.38
Bid0.00 x
Ask0.00 x
Day's Range81.14 - 82.05
52 Week Range64.18 - 83.79
Volume577,776
Avg. Volume6,115,634
Market Cap85.58B
Beta0.24
PE Ratio (TTM)31.64
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (2.59%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Investopedia56 minutes ago

    Amgen Signs Value-Based Deal for Enbrel

    The deal serves a dual purpose: Deliver better value to patients and preserve the drug's market share.

  • CNBC18 hours ago

    Eli Lilly CEO supports Trump's 'blueprint' for growth

    In an exclusive interview on CNBC's "Power Lunch," Eli Lilly CEO David Ricks explained why he supported a new tax system under Trump.

  • American City Business Journals19 hours ago

    In 'groundbreaking' deal, Harvard Pilgrim negotiates contracts to save on two pricey drugs

    Harvard Pilgrim Health Care has negotiated new payment contracts with two pharmaceutical companies for expensive drugs, progressing a new kind of payment model that could save millions of dollars down the line. If not, the insurer receives a rebate from the pharmaceutical company, which trickles down into more stable premiums for members. “If you think about it, this is considered groundbreaking but it shouldn’t be,” said Michael Sherman, chief medical officer and senior vice president for health services at Harvard Pilgrim.